Athenex Appoints Darrel P. Coh - GuruFocus.com
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Source: gurufocus.com
📰 Src Kinase News
Src Kinase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Src Kinase. Real-time updates on events, politics, business and more.
Athenex Partners with Leading Contract Manufacturer GenScript ProBio in the Development of Advanced Cell and Gene Therapies
Over the past ten years, Athenex has established a productive relationship with GenScript and GenScript ProBio as a provider of high-quality reagents and materials to support multiple Research and Development initiatives
Dan Lang Genscript Probio Pressreleasepoint Genscript Probio Athenex Inc Script Probio President Athenex Cell
Source: pressreleasepoint.com
Athenex Appoints Darrel P. Cohen, MD, PhD as Chief Medical
BUFFALO, N.Y., June 08, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
Source: globenewswire.com
Athenex: Q1 Earnings Insights
52-week low: $3.66 Company Profile Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through c...
Source: benzinga.com